MedPath

Cephalexin

Cephalexin 500mg Capsules

Approved
Approval ID

af10128f-021a-14b7-e053-2a95a90a4365

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 18, 2024

Manufacturers
FDA

ADVANCED RX PHARMACY OF TENNESSEE, LLC

DUNS: 117023142

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cephalexin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80425-0005
Application NumberANDA065229
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cephalexin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 18, 2024
FDA Product Classification

INGREDIENTS (1)

CEPHALEXINActive
Quantity: 500 mg in 1 1
Code: OBN7UDS42Y
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cephalexin - FDA Drug Approval Details